Casdin Capital, LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26,819,000
-30.1%
1,300,0000.0%2.97%
-11.5%
Q2 2023$38,363,000
+28.1%
1,300,0000.0%3.35%
+35.9%
Q1 2023$29,952,000
-17.2%
1,300,0000.0%2.47%
-11.9%
Q4 2022$36,153,000
+18.4%
1,300,000
+30.7%
2.80%
+39.6%
Q3 2022$30,537,000
-30.8%
995,000
-33.7%
2.01%
-46.3%
Q2 2022$44,145,000
-8.5%
1,500,0000.0%3.73%
+72.5%
Q1 2022$48,255,000
-27.9%
1,500,0000.0%2.16%
+14.7%
Q4 2021$66,900,000
-22.0%
1,500,000
-11.8%
1.89%
-11.7%
Q3 2021$85,765,000
-32.1%
1,700,000
+5.6%
2.14%
-33.4%
Q2 2021$126,288,000
+37.4%
1,610,0000.0%3.21%
+17.1%
Q1 2021$91,931,000
-16.2%
1,610,000
+22.9%
2.74%
-15.8%
Q4 2020$109,726,000
+133.8%
1,310,0000.0%3.25%
+54.7%
Q3 2020$46,937,000
+48.2%
1,310,0000.0%2.10%
+12.1%
Q2 2020$31,676,000
+24.3%
1,310,000
-10.0%
1.88%
-30.7%
Q1 2020$25,477,000
+17.0%
1,455,000
+16.4%
2.70%
+35.1%
Q4 2019$21,775,000
-99.8%
1,250,000
+92.3%
2.00%
+94.2%
Q3 2019$9,958,000,000
+19.9%
650,000
+62.5%
1.03%
+32.7%
Q2 2019$8,304,000,000
+357522.7%
400,000
+300.0%
0.78%
+204.7%
Q1 2019$2,322,000
+12.4%
100,0000.0%0.26%
-27.8%
Q4 2018$2,066,000100,0000.35%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders